Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial
Background - The CAO/ARO/AIO trial has shown that oxaliplatin added to preoperative chemoradiotherapy and postoperative chemotherapy significantly improved disease-free survival in locally advanced rectal cancer (LARC). Here, we present a post-hoc analysis of quality of life (QoL) in disease-free pa...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 2021
|
| In: |
European journal of cancer
Year: 2021, Volume: 144, Pages: 281-290 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2020.11.029 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejca.2020.11.029 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804920313666 
|
| Author Notes: | Rebekka Kosmala, Emmanouil Fokas, Michael Flentje, Rolf Sauer, Torsten Liersch, Ullrich Graeven, Rainer Fietkau, Werner Hohenberger, Dirk Arnold, Ralf-Dieter Hofheinz, Michael Ghadimi, Philipp Ströbel, Ludger Staib, Gerhard G. Grabenbauer, Gunnar Folprecht, Simon Kirste, Wolfgang Uter, Christine Gall, Claus Rödel, Bülent Polat |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1754879624 | ||
| 003 | DE-627 | ||
| 005 | 20240413193256.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210414s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2020.11.029 |2 doi | |
| 035 | |a (DE-627)1754879624 | ||
| 035 | |a (DE-599)KXP1754879624 | ||
| 035 | |a (OCoLC)1341404603 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kosmala, Rebekka |e VerfasserIn |0 (DE-588)1231409797 |0 (DE-627)1754879888 |4 aut | |
| 245 | 1 | 0 | |a Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial |c Rebekka Kosmala, Emmanouil Fokas, Michael Flentje, Rolf Sauer, Torsten Liersch, Ullrich Graeven, Rainer Fietkau, Werner Hohenberger, Dirk Arnold, Ralf-Dieter Hofheinz, Michael Ghadimi, Philipp Ströbel, Ludger Staib, Gerhard G. Grabenbauer, Gunnar Folprecht, Simon Kirste, Wolfgang Uter, Christine Gall, Claus Rödel, Bülent Polat |
| 264 | 1 | |c February 2021 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.04.2021 | ||
| 520 | |a Background - The CAO/ARO/AIO trial has shown that oxaliplatin added to preoperative chemoradiotherapy and postoperative chemotherapy significantly improved disease-free survival in locally advanced rectal cancer (LARC). Here, we present a post-hoc analysis of quality of life (QoL) in disease-free patients. - Patients and methods - Between 2006 and 2010, 1236 patients with LARC were randomly assigned either to preoperative chemoradiotherapy followed by total mesorectal excision and postoperative chemotherapy (N = 623) or combined with oxaliplatin (N = 613). QoL questionnaires (EORTC QLQ-C30, colorectal module CR38) were completed at baseline, after postoperative chemotherapy and during follow-up. Analysis was performed according intent-to-treat. - Results - Available questionnaires (baseline) were 82% (N = 512) in the control and 84% (N = 513) in the investigational group. Response rates were 49% (533 of 1086) at 1 year and 43% (403 of 928) at 3 years. Global health status (GHS) for disease-free patients was stable in both groups (range 0-100). At baseline: standard arm 62.0 (mean, SD 21.6; N = 491) versus oxaliplatin arm 63.2 (mean, SD 22; N = 503); at 3 years: 69.4 (SD 19.3; N = 187) versus 65.4 (SD 22.2; N = 202). After treatment and at 3 years, no significant differences (≥10 points) between groups were found in QoL subscales. Disease-free patients experiencing neurotoxic side-effects (grade 1-4) showed reduced GHS at 3 years versus patients without neurotoxicity (mean 59.2 versus 69.3; P < 0.001), while grade 3-4 rate was low. - Conclusion - The addition of oxaliplatin was not associated with worse overall QoL. This information is of interest to patients in many ongoing rectal cancer trials. - Trial registration information - NCT00349076. | ||
| 650 | 4 | |a Chemoradiotherapy | |
| 650 | 4 | |a Oxaliplatin | |
| 650 | 4 | |a Quality of life | |
| 650 | 4 | |a Rectal neoplasms | |
| 700 | 1 | |a Fokas, Emmanouil |e VerfasserIn |4 aut | |
| 700 | 1 | |a Flentje, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sauer, Rolf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Liersch, Torsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Graeven, Ullrich |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fietkau, Rainer |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hohenberger, Werner |e VerfasserIn |4 aut | |
| 700 | 1 | |a Arnold, Dirk |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |e VerfasserIn |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 aut | |
| 700 | 1 | |a Ghadimi, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ströbel, Philipp |e VerfasserIn |4 aut | |
| 700 | 1 | |a Staib, Ludger |e VerfasserIn |4 aut | |
| 700 | 1 | |a Grabenbauer, Gerhard G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Folprecht, Gunnar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kirste, Simon |e VerfasserIn |4 aut | |
| 700 | 1 | |a Uter, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gall, Christine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rödel, Claus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Polat, Bülent |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 144(2021), Seite 281-290 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial |
| 773 | 1 | 8 | |g volume:144 |g year:2021 |g pages:281-290 |g extent:10 |a Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejca.2020.11.029 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0959804920313666 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210414 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 65500 |e 60000PH121917517 |e 65500PH121917517 |k 0/60000/ |k 1/60000/65500/ |p 10 | ||
| 999 | |a KXP-PPN1754879624 |e 390937851X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"titleAlt":[{"title":"EJC online"}],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"role":"isb","display":"European School of Oncology"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"pubHistory":["28.1992 -"],"origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1992-","dateIssuedKey":"1992","publisher":"Elsevier ; Pergamon Press"}],"id":{"eki":["266883400"],"issn":["1879-0852"],"zdb":["1468190-0"]},"part":{"year":"2021","extent":"10","text":"144(2021), Seite 281-290","volume":"144","pages":"281-290"},"recId":"266883400","disp":"Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trialEuropean journal of cancer"}],"note":["Gesehen am 14.04.2021"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"February 2021"}],"id":{"eki":["1754879624"],"doi":["10.1016/j.ejca.2020.11.029"]},"recId":"1754879624","name":{"displayForm":["Rebekka Kosmala, Emmanouil Fokas, Michael Flentje, Rolf Sauer, Torsten Liersch, Ullrich Graeven, Rainer Fietkau, Werner Hohenberger, Dirk Arnold, Ralf-Dieter Hofheinz, Michael Ghadimi, Philipp Ströbel, Ludger Staib, Gerhard G. Grabenbauer, Gunnar Folprecht, Simon Kirste, Wolfgang Uter, Christine Gall, Claus Rödel, Bülent Polat"]},"title":[{"title":"Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial","title_sort":"Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial"}],"person":[{"given":"Rebekka","role":"aut","family":"Kosmala","display":"Kosmala, Rebekka"},{"family":"Fokas","role":"aut","given":"Emmanouil","display":"Fokas, Emmanouil"},{"family":"Flentje","role":"aut","given":"Michael","display":"Flentje, Michael"},{"display":"Sauer, Rolf","role":"aut","given":"Rolf","family":"Sauer"},{"family":"Liersch","role":"aut","given":"Torsten","display":"Liersch, Torsten"},{"family":"Graeven","role":"aut","given":"Ullrich","display":"Graeven, Ullrich"},{"display":"Fietkau, Rainer","family":"Fietkau","given":"Rainer","role":"aut"},{"display":"Hohenberger, Werner","family":"Hohenberger","given":"Werner","role":"aut"},{"given":"Dirk","role":"aut","family":"Arnold","display":"Arnold, Dirk"},{"display":"Hofheinz, Ralf-Dieter","role":"aut","given":"Ralf-Dieter","family":"Hofheinz"},{"display":"Ghadimi, Michael","given":"Michael","role":"aut","family":"Ghadimi"},{"display":"Ströbel, Philipp","role":"aut","given":"Philipp","family":"Ströbel"},{"display":"Staib, Ludger","given":"Ludger","role":"aut","family":"Staib"},{"display":"Grabenbauer, Gerhard G.","family":"Grabenbauer","given":"Gerhard G.","role":"aut"},{"role":"aut","given":"Gunnar","family":"Folprecht","display":"Folprecht, Gunnar"},{"display":"Kirste, Simon","family":"Kirste","given":"Simon","role":"aut"},{"family":"Uter","role":"aut","given":"Wolfgang","display":"Uter, Wolfgang"},{"role":"aut","given":"Christine","family":"Gall","display":"Gall, Christine"},{"role":"aut","given":"Claus","family":"Rödel","display":"Rödel, Claus"},{"display":"Polat, Bülent","family":"Polat","given":"Bülent","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"10 S."}],"language":["eng"]} | ||
| SRT | |a KOSMALAREBQUALITYOFL2021 | ||